NeuroX Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
NeuroX Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers
GUIDE（改進癡呆體驗）模型旨在增加護理協調，支持看護人員。
JACKSONVILLE, Fla., July 9, 2024 /PRNewswire/ -- Today, NeuroX announced they have been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers. Under CMS' Guiding an Improved Dementia Experience (GUIDE) Model, NeuroX will be one of almost 400 participants building Dementia Care Programs (DCPs) across the country, working to increase care coordination and improve access to services and supports, including respite care, for people living with dementia and their caregivers.
2024年7月9日，美國，佛羅里達州傑克遜維爾 /美通社/--今天，NeuroX宣佈，他們已被中心選擇參加由醫療保險與醫療補助總署所組織的新的醫療保險替代支付模式（MAPD），旨在支持患有癡呆症和他們的看護人員的人們。 在CMS的GUIDE（改進癡呆體驗）模型下，NeuroX將成爲全國近400個參與者之一，建立癡呆照料方案（DCPs），努力增加協調護理並改善服務和支持的接入，包括休息照料，給患有癡呆症的人和他們的看護人員使用。
"CMS is excited to partner with NeuroX under the GUIDE Model," said CMS Administrator Chiquita Brooks-LaSure. "GUIDE is a new approach to how Medicare will pay for the care of people living with dementia. The GUIDE participants are envisioning new ways to support not only people living with dementia, but also to reduce strain on the people who care for them, so that more Americans can remain in their homes and communities, rather than in institutions."
“CMS很高興能與NeuroX合作GUIDE模型，”CMS局長Chiquita Brooks-LaSure表示。“GUIDE是一個新的方法，醫保將爲患有癡呆症的人支付護理。GUIDE參與者正在設想支持患有癡呆症的人新的方式，同時減輕他們看護人的負擔，以便更多的美國人可以留在家裏和社區，而不是在機構裏。”
Launched on July 1, 2024, the GUIDE Model will test a new payment approach for key supportive services furnished to people living with dementia, including: comprehensive, person-centered assessments and care plans; care coordination; 24/7 access to an interdisciplinary care team member or help line; and certain respite services to support caregivers. People with dementia and their caregivers will have the assistance and support of a Care Navigator to help them access clinical and non-clinical services such as meals and transportation through community-based organizations.
GUIDE 模型於2024年7月1日啓動，將測試提供給患有癡呆症的人的關鍵支持服務的新支付方法，包括：全面的以人爲中心的評估和護理計劃;協調護理;全天候訪問跨學科護理團隊成員或熱線幫助;以及某些緩解看護人員的旁觀服務。 患有癡呆症的人及其看護人員將有一個護理導航員的幫助和支持，幫助他們通過社區組織獲得臨床和非臨床服務，如餐食和交通。
"We applaud CMS for introducing this comprehensive approach to enhance care for dementia patients and support their caregivers," said Dr. Muhammad "Umar" Farooq, Chief Medical Officer at NeuroX. "Dementia is not merely a disease affecting an individual; it imposes a significant socio-economic burden on the entire family. As a physician-led population health management company, our strategy for developing a dementia care program under the GUIDE Model is multifaceted. We are honored to collaborate with CMS to ensure quality, timely care delivery for those in need."
“我們爲CMS引入這種綜合方法以增強癡呆症患者的護理並支持他們的看護人員而鼓掌。”NeuroX首席醫療官Dr.Muhammad“Umar”Farooq說：“癡呆症不僅是一個影響個體的疾病，而是對整個家庭造成了重大的社會經濟負擔。作爲一個以醫師爲領導的人群健康管理公司，我們制定GUIDE模型下的癡呆照料計劃的策略是多方面的。我們很榮幸能與CMS合作，確保及時提供高質量的護理。
"GUIDE is the latest innovative CMS value based program focused on improving clinical quality while lowering health care expenditures for Medicare," said NeuroX Chief Operating Officer David Spalding, an industry veteran with extensive experience in Medicare Shared Savings Program ACOs and kidney-based value-based care. "As a GUIDE participant, ATP will deploy our scalable, award winning brain health care management platform to support our proprietary specialist telemedicine network and in conjunction with community-based physician groups focused on senior populations with chronic conditions."
“GUIDE是最新的創新CMS價值編制程序，專注於提高臨床質量，同時降低醫療保健支出。” NeuroX首席運營官David Spalding說，他在醫療保健共享儲蓄程序ACO和基於腎臟的價值醫療保健方面擁有豐富的經驗。“作爲GUIDE參與者，ATP將部署我們可擴展的，獲獎的大腦健康護理管理平台，以支持我們的專有專家遠程醫療網絡，並與專注於慢性病患者的老年人群體的社區醫療組合作。”
Dr. Waqas Ahmed, founder and CEO of NeuroX, adds, "Being selected as a participant in the CMS GUIDE program marks a significant milestone for NeuroX and underscores our commitment to. revolutionizing brain health care accessibility. Our vision has always been aligned with CMS's goal of enhancing dementia care for patients at home. This opportunity allows us to further amplify our impact and drive positive change in the lives of individuals and families affected by neurological conditions."
NeuroX創始人兼首席執行官Waqas Ahmed補充說：“被選爲CMS GUIDE計劃的參與者是NeuroX標誌性里程碑，突顯了我們致力於改變大腦健康護理可及性的承諾。我們的願景一直與CMS的目標是提高患有癡呆症的患者在家的護理一致。這次機會讓我們能進一步擴大我們的影響力，並推動對神經疾病受影響者和家庭的積極變革。”
NeuroX participation in the GUIDE Model will help people living with dementia and their caregivers have access to education and support, such as training programs on best practices for caring for a loved one living with dementia. The GUIDE Model also provides respite services for certain people, enabling caregivers to take temporary breaks from their caregiving responsibilities. Respite is being tested under the GUIDE Model to assess its effect on helping caregivers continue to care for their loved ones at home, preventing or delaying the need for facility care.
參與GUIDE模型的NeuroX將幫助患有癡呆症的人及其看護人員獲得教育和支持，例如有關最佳照顧患有癡呆症的愛人的培訓課程。 GUIDE模型還爲某些人提供旁觀服務，使看護人員能夠暫時從看護職責中暫時休息。GUIDE模型正在測試旁觀服務，以評估其對幫助看護人員繼續在家照顧他們的親人，延遲或防止機構護理的效果。
GUIDE Participants represent a wide range of health care providers, including large academic medical centers, small group practices, community-based organizations, health systems, hospice agencies, and other practices.
GUIDE參與者代表了範圍廣泛的醫療保健提供者，包括大型學術醫療中心，小型醫療小組，基於社區的組織，衛生系統，臨終關懷機構和其他機構。
This model delivers on a promise in the Biden Administration's Executive Order on Increasing Access to High-Quality Care and Supporting Caregivers and aligns with the National Plan to Address Alzheimer's Disease. For more information on CMS' GUIDE Model, please visit: .
這個模型兌現了拜登政府的行政命令，增加高質量護理和支持看護人員，並與應對阿爾茨海默病的國家計劃保持一致。有關CMS GUIDE模型的更多信息，請訪問:
About NeuroX:
NeuroX () is an award winning healthcare company dedicated to revolutionizing brain health through innovative technology and comprehensive care solutions. By integrating neurology, mental health, and sleep medicine services under one umbrella, NeuroX delivers value-based care to patients and families dealing with costly and complex brain-related health conditions. NeuroX is a division of American TelePhysicians, founded in 2017 by a team of physicians and IT professionals under the leadership of Waqas Ahmed, MD FACP. American TelePhysicians' vision is to transform the global healthcare industry by incubating customized healthcare ecosystems, and by bringing affordable medical services to all patients, including underserved communities. American TelePhysicians achieves this through various projects, including CURA4U, SmartClinix, and NeuroX. For more information, visit .
關於NeuroX:
NeuroX（）是一家致力於通過創新技術和全面的護理方案改變大腦健康的獲獎醫療保健公司。通過在一個框架下整合神經科、心理健康和睡眠醫學服務，NeuroX向處理成本高昂且複雜的與大腦相關的健康狀況的患者和家庭提供價值基於護理。 NeuroX是由Waqqas Ahmed博士（MD FACP）擔任首席執行官的醫師領導的人群健康管理公司，成立於2017年。美國電視醫師的願景是通過孵化定製醫療保健生態系統，併爲包括未得到服務的社區在內的所有患者提供可負擔得起的醫療服務來改變全球醫療保健行業。美國電視醫師通過各種項目實現這一目標，包括CurA4U、SmartClinix和NeuroX。欲了解更多信息，請訪問。
For media inquiries, please contact:
Sherri Johnson
NeuroX
770-265-0728
[email protected]
媒體垂詢，請聯繫：
Sherri Johnson
NeuroX
770-265-0728
[email protected]
SOURCE American TelePhysicians
美通社